Items where Author is "Ziaee, M."

(2020) SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial. Clinical Infectious Diseases. pp. 2206-2212. ISSN 1058-4838

(2018) Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran. Archives of Virology. pp. 1479-1488. ISSN 0304-8608

(2018) SD1000: 96.4 SVR12 in 1237 patients with hepatitis C genotypes 1, 2, 3, 4 using co-formulated sofosbuvir/daclatasvir tablets manufactured in Iran - a multicenter phase 3 clinical trial including HIV co-infected, transplant, and hemodialysis patients. Journal of Viral Hepatitis. pp. 198-199. ISSN 1352-0504

(2016) Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepatitis Monthly. ISSN 1735-143X

(2015) Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces. Iranian journal of microbiology. pp. 214-20. ISSN 2008-3289 (Print) 2008-3289 (Linking)